Marketing Authorisation for MAGHP

15. Mai 2020 – For the first time, Swissmedic authorises a medicinal product under the Marketing Authorisation for Global Health Products (MAGHP). For further information, see: https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/authorisations/information/first-maghp-approval-inswitzerland.html.